Manmeet Singh Soni is President & COO +1 at REATA PHARMACEUTICALS INC (RETA). They have made 14 open-market trades across 4 companies since 2014, most recently 2026-06-04.
CIK 0001569769
4 open-market purchases totalling $11.4M since 2020, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SMMT | 3,123,603 | $45.7M |
| RETA | 62,621 | $10.8M |
| ARNA | 5,902 | $590K |
| ALNY | 2 | $464 |
| PCYC | 873 | — |
| Total | $57.1M |
Shares reported on the most recent Form 4, priced at the 2026-06-04 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SMMT | BUY | 2026-06-04 | 2026-06-04 | $14.45 | $722K | -9.1% | +4.4% | -4.3% |
| SMMT | BUY | 2023-10-13 | 2023-10-16 | $1.68 | $10.0M | +1.6% | +6.5% | +86.0% |
| RETA | SELL | 2023-08-16 | 2023-08-17 | $168.41 | $591K | -0.1% | +1.8% | N/A |
| RETA | SELL · 10b5-1 | 2023-07-28 | 2023-08-01 | $164.62 | $12.3M | +0.9% | +1.8% | N/A |
| RETA | SELL | 2023-06-12 | 2023-06-14 | $102.70 | $17.0M | -8.5% | +8.1% | +70.3% |
| RETA | SELL | 2023-05-15 | 2023-05-17 | $84.45 | $3.7M | +10.2% | +14.7% | +107.8% |
| RETA | SELL | 2023-03-07 | 2023-03-08 | $84.70 | $105K | +9.4% | +15.0% | +15.0% |
| RETA | SELL | 2023-03-03 | 2023-03-06 | $87.97 | $631K | +2.8% | +6.0% | +5.3% |
| RETA | BUY | 2021-12-31 | 2022-01-04 | $26.22 | $420K | -1.6% | -9.1% | +24.8% |
| RETA | BUY | 2020-08-14 | 2020-08-14 | $100.21 | $301K | -1.4% | -1.9% | +68.6% |
| ARNA | SELL · 10b5-1 | 2020-06-17 | 2020-06-18 | $62.74 | $19K | -1.1% | +6.5% | +9.9% |
| ARNA | SELL | 2020-06-15 | 2020-06-16 | $60.12 | $160K | +5.1% | +6.5% | +7.1% |
| ARNA | SELL | 2019-06-14 | 2019-06-17 | $55.89 | $136K | +1.5% | +7.5% | -8.3% |
| ARNA | SELL | 2019-06-14 | 2019-06-17 | $55.82 | $61K | +1.5% | +7.5% | -8.3% |
| PCYC | SELL | 2015-03-11 | 2015-03-13 | $254.24 | $7.0M | N/A | N/A | N/A |
| PCYC | SELL | 2014-11-13 | 2014-11-17 | $141.44 | $141K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.